BioSpace News Archive

Multiple Sulfatase Deficiency is an ultra-rare monogenic lysosomal disorder caused by mutations in the evolutionarily conserved gene SUMF1

Proceeds Will Help to Advance the Company’s Cancer Epigenetics Platform and Accelerate Development of Ongoing Therapeutic Programs

Angiograms are common procedures used to diagnose many conditions, according to the SVS, and vascular surgeons use them to find out if you have a blockage in one of your arteries.

The Ultra-High Resolution CT System Delivers Twice the Resolution of Today’s CT Systems

Ionis earns $30 million license fee for IONIS-AZ6-2.5-L Rx

Merck announced that the pivotal Phase 3 KEYNOTE-042 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC, including nonsquamous or squamous histologies) met its primary endpoint of overall survival (OS).

Cellect Biotechnology Ltd. announced that it has successfully completed the proof of concept testing of its first in type new product prototype, ApoTainer™ using Cellect’s FasL-coated magnetic beads for maximizing efficacy and scalability of stem cell based products’ manufacturing.

DUOBRII Demonstrated Significant Superiority Over Vehicle As Early As Two Weeks

Company strengthens leadership team with appointments and promotions in key roles for next stage of growth.

Close to half of drug discovery research will be contracted to CROs is a good estimate based on in-the-know contacts and research.